Intelligent Bio Solutions

Intelligent Bio Solutions Stock-Based Compensation

The Stock-Based Compensation (SBC) of Intelligent Bio Solutions (INBS) as of Oct 21, 2026 is 195,208.00 USD. In the previous year, Stock-Based Compensation (SBC) was 238,045.00 USD — a change of -18.00% (lower).

Stock-Based Compensation

195,208.00USD

YoY

-18.00%

Last updated:

Stock-Based Compensation (SBC) of Intelligent Bio Solutions is 2026 195,208.00 USD. Stock-Based Compensation (SBC) of Intelligent Bio Solutions was 2025 238,045.00 USD. It decreases by -18.00% lower compared to the previous year.

The Intelligent Bio Solutions Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
1.95 M USD
Jan 1, 2020
900,000.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
260,000.00 USD
Jan 1, 2024
230,496.00 USD
Jan 1, 2025
238,045.00 USD
Jan 1, 2026
195,208.00 USD
The Intelligent Bio Solutions Stock-Based Compensation history
YEARStock-Based CompensationYoY
195,208.00USD-18.00%
238,045.00USD+3.28%
230,496.00USD-11.35%
260,000.00USD—
0.00USD-100.00%
900,000.00USD-53.85%
1.95 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligent Bio Solutions stock

Stock-Based Compensation (SBC) of Intelligent Bio Solutions is 195,208.00 USD in 2026.

Stock-Based Compensation (SBC) of Intelligent Bio Solutions changed from 238,045.00 USD to 195,208.00 USD, representing a -18.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Intelligent Bio Solutions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions